The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-British stocks up on China tariff cut; Royal Mail skids

Thu, 06th Feb 2020 09:02

* FTSE 100, FTSE 250 up 0.3%

* China to reduce tariffs on some U.S. imports

* Royal Mail skids after trading update

* Beazley up on higher FY earnings
(Adds news items, analyst comments, updates share prices)

By Shashwat Awasthi

Feb 6 (Reuters) - UK shares advanced for a fourth straight
session on Thursday as risk sentiment picked up after China
pledged to halve tariffs on some U.S. imports, though Royal Mail
slid to an all-time low after warning of a challenging year
ahead.

China will cut additional tariffs levied against 1,717 U.S.
goods last year, after a Phase 1 trade deal was signed last
month, and as fears persist over the coronavirus outbreak, which
has killed more than 550 people.

The FTSE 100 rose 0.3%. The FTSE 250 added 0.4%, as
insurer Beazley gained 6% after its 2019 profit surged.

Royal Mail sank 8% after the letter carrier warned
outlook for the 2020-21 fiscal year was "challenging" and said
the threat of a labour strike in late 2019 hurt parcel revenue
growth during the Christmas period.

The company's strained relationship with the CWU union,
which has called for a strike ballot, "bodes ill for both
business as usual productivity improvements and reaping the
benefits of the medium-term strategy," Liberum analyst Gerald
Khoo wrote.

Global markets have been attempting a recovery after sharp
losses last week, and were given a shot in the arm on Wednesday
by media reports that scientists had developed a drug against
the China-linked virus.

Though the World Health Organisation played down the
reports, hopes that the outbreak would soon be contained as well
as upbeat economic data from the United States helped boost
stock bourses.

"The momentum is clearly with the bulls at the moment, and
we see no reason to stand against that tide," OANDA analyst
Jeffrey Halley said.

"The potential for an aggressive and rapid correction lower
still lurks though, if negative Wuhan virus headlines emerge,"
he warned, adding that economic data for January was yet to show
any severe spillover in growth from the virus.

GlaxoSmithKline slipped 3.6%, following a more than
4% drop in the previous session when its fourth-quarter earnings
missed analysts' estimates.

NMC Health, whose shares have been battered after
criticism from short-seller Muddy Waters late last year, was up
3% after soaring as much as 13% in early deals.

A Financial Times report https://www.ft.com/content/0cc7ce7e-481e-11ea-aee2-9ddbdc86190d
overnight said the company's founder was looking to return to
an "active leadership position".
(Reporting by Shashwat Awasthi in Bengaluru; Editing by Bernard
Orr)

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.